Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
07/2010
07/01/2010WO2010073544A1 Method for testing risk of coronary artery diseases
07/01/2010WO2010072109A1 A sustained release system for tumor treating medicament
07/01/2010WO2010044094A3 A topical composition for the treatment of erectile dysfunction
07/01/2010WO2009147009A3 Compositions comprising atorvastatin 4-(nitrooxy) butyl ester and a hypolipidemic drug
07/01/2010WO2009071903A8 Composition comprising a chondroitin sulphate proteoglycan inhibitory agent and an anti-inflammatory agent
07/01/2010US20100168246 Amine compounds and inhibiting neurotransmitter reuptake
07/01/2010US20100168152 Fat regulation
07/01/2010US20100168052 Treatment of EBV and KHSV Infection and Associated Abnormal Cellular Proliferation
07/01/2010US20100168031 Lat peptides and their use in assays for identifying immunosuppressants
07/01/2010US20100167275 Potassium channel mutants of the yeast Saccharomyces cerevisiae and their use for screening eukaryotic potassium channels
07/01/2010US20100166827 Periostin induces proliferation of cardiomyocytes and promotes cardiac regeneration
07/01/2010US20100166733 Mcp-1 splice variants and methods of using same
07/01/2010US20100166715 T-140 peptide analogs having cxcr4 super-agonist activity for bone marrow recovery
07/01/2010US20100166714 Cardiovascular stem cells, methods for stem cell isolation, and uses thereof
06/2010
06/30/2010EP2202240A1 Compound
06/30/2010EP2201964A2 Formoterol superfine formulation
06/30/2010EP2201963A1 Glutamate modulating agents in the treatment of mental disorders
06/30/2010EP2201952A1 Omeprazole dosage forms and their use
06/30/2010EP2200649A2 Compositions and methods for ameliorating cns inflammation, psychosis, delirium, ptsd or ptss
06/30/2010EP2200648A1 Mitogen-activated protein kinase kinase kinase 14 (map3k14) polymorphisms as indicators of subject outcome in critically ill subjects
06/30/2010EP1545548B1 The use of the combination of ciclesonide and antihistamines for the treatment of allergic rhinitis
06/30/2010EP1516881B1 Composition and method for modulating dendritic Cell-T cell interaction
06/30/2010EP1332366B1 Methods for the Assessment of Cellular Proliferative Disorders
06/30/2010CN101765373A Compositions and methods for cell killing
06/30/2010CN101759882A Sephadex magnetic composite particles and preparation and use thereof
06/30/2010CN101759812A Novel chitosan derivative simulating the structure of cell-penetrating peptide
06/30/2010CN101757629A Medicine composition for treating acute and chronic aryngitis and preparation method thereof
06/30/2010CN101757628A Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology
06/30/2010CN101757627A Combined drug and drug combination for treating diabetes
06/30/2010CN101757626A Pharmaceutical composition containing insulin-like growth factor-I receptor inhibitor and histon deacetylase (HDAC) inhibitor and application thereof
06/30/2010CN101757625A Nasal pharmaceutical composition of cyclodextrin inclusion cortin and H1 receptor antagonist
06/30/2010CN101757624A Composite for preventing and curing senile dementia
06/30/2010CN101757623A 5-HT receptor agonist solid pharmaceutical composition
06/30/2010CN101757622A Drug composition for ocular inflammation resistance
06/30/2010CN101757621A Cyclodextrin inclusion drug composition for ocular inflammation resistance
06/30/2010CN101757470A Blood fat lowering composition
06/30/2010CN101756957A Pharmaceutical composition containing artemisinin, artemisinin derivatives and histon deacetylase (HDAC) inhibitor and application thereof
06/30/2010CN101756941A Drug-reservoir type scar-removing silicone gel paster and preparation method thereof
06/30/2010CN101756908A Hydroxyapatite micro-sphere with polyester coating and preparation method thereof
06/30/2010CN101756885A Displeased taste and oral liquid preparation with reduced odor
06/30/2010CN101322848B Composition for gastroscopy and preparation thereof
06/29/2010US7745639 Dihydropyrazoles; anticarcinogenic agents can be synergistically combined with one or more active ingredients; side effect reduction
06/29/2010US7745606 polynucleotides used for modulating immune responses; immunotherapy
06/29/2010US7745604 genetic enhancers comprising the nucleotide sequences that elevates transcription of a heterologous coding sequence in a host cell
06/29/2010US7745581 T-bet compositions and methods of use thereof
06/29/2010US7745499 determining removability performance of the virus removal membrane; storage stability and pH stability, being useful as viral substitute particles for use in an integrity test for virus removal membrane
06/29/2010US7745493 acamprosate; Parkinson's disease or Huntington's disease
06/29/2010US7745488 Therapy for neutropenia as result of radiation therapy; administering colony stimulating factor
06/29/2010US7745472 Dimethylsulfamic Acid 2-bromo-4-{[(4-cyano-phenyl)-[1,2,4]triazol-4-ylamino]methyl}phenyl Ester, used as effective sulfatase and/or aromatase inhibitors, and as modulators of cell cycling and modulators of apoptosis; therapy of breast, prostate, ovarian or endometrial cancer
06/29/2010US7745445 Compounds and compositions as PPAR modulators
06/29/2010US7745444 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
06/29/2010US7745406 Kit which determines concentration of phosphate metabolizing protein and utilizes profile as indicator of hypo/hyperphosphatemic disorders
06/29/2010US7745388 Peptide for use in the treatment of cell damage caused by ischemia
06/29/2010US7745114 Compositions and methods for identifying and targeting cancer cells of alimentary canal origin
06/29/2010US7745112 predicting a response of a human subject to a nicotine replacement treatment designed to assist smoking cessation; screening a smokers DNA for the presence and genotype of dopamine beta -hydroxylase 1368 alleles and dopamine D2 receptor Taq I RFLP alleles; nicotine replacement treatment
06/29/2010US7745109 Regulation of cell growth by MUC1
06/29/2010US7744921 Liposome loading with metal ions
06/29/2010US7744909 Dispersions for the formulation of slightly or poorly soluble agents
06/29/2010US7744888 Controlling immunology response; autoimmune disease, antiallergens
06/29/2010US7744878 Antibodies that bind to cancer-associated antigen CD46 and methods of use thereof
06/29/2010US7744873 Extracting DNA from a blood or buccal cell sample, PCR, resolution, and identification of differences in sequences between the extracted DNA and PCR primers; drug screening
06/29/2010US7744867 Anticancer, antitumor agents
06/29/2010US7744864 Method for identifying a patient at risk of having difficulty in sustaining a pregnancy
06/29/2010CA2575521C Medicinal composition containing diabetes remedy
06/29/2010CA2504065C Dispersible antibacterial pharmaceutical compositions
06/29/2010CA2453117C Oral dosage forms comprising a benzimidazole and buffer
06/29/2010CA2448273C Drug delivery system comprising a tetrahydroxylated estrogen for use in hormonal contraception
06/29/2010CA2426885C Complexes of phosphate derivatives
06/29/2010CA2418070C Hybrid neuroprosthesis for the treatment of brain disorders
06/29/2010CA2405521C Macrocyclic ns3-serine protease inhibitors of hepatitis c virus comprising n-cyclic p2 moieties
06/29/2010CA2404737C Drug delivering substance containing polyalkylene glycol and phospholipid covalently bonded to drug
06/29/2010CA2401942C Pharmaceutical compositions for buccal and pulmonary application
06/29/2010CA2379734C Treatment of cancers
06/29/2010CA2366765C Vacuolar-type (h+) -atpase-inhibiting compounds, compositions, and uses thereof
06/29/2010CA2357114C Use of melatonin in the manufacture of a medicament for treating attention deficit hyperactive disorder
06/29/2010CA2355814C Pharmaceutical composition for ophthalmic use
06/29/2010CA2350396C A composition useful to treat periodontal disease
06/29/2010CA2337969C Compound and method for the prevention and/or the treatment of allergy
06/29/2010CA2336593C Methods and compositions for treatment of disorders associated with chlamydial and similar bacterial infection
06/29/2010CA2312936C Compositions and methods for weight reduction
06/29/2010CA2286795C Use of one-dimensional nuclear magnetic resonance to identify ligands to target biomolecules
06/29/2010CA2187740C Dna encoding bradykinin b1 receptor
06/24/2010WO2010071866A2 Combination therapy for arthritis with tranilast
06/24/2010WO2010071865A1 Pharmaceutical compositions and methods for treating hyperuricemia and related disorders
06/24/2010WO2010071230A1 Photodynamic therapeutic agent showing accumulation of cell-specific functions
06/24/2010WO2010070379A1 Rxr-ppargamma agonist/growth factor inhibitor combination therapy for inducing apoptosis and the treatment of cancer
06/24/2010WO2010069493A1 Improved combination of active agents comprising an antibiotic and a non-steroidal anti-inflammatory drug (nsaid)
06/24/2010WO2010049709A3 Therapeutic compositions comprising phenolic acids for treating conditions related to inap proriate platelet aggregation
06/24/2010WO2010049705A3 Therapeutic compositions comprising flavonoids
06/24/2010US20100160721 Cardiac support device with differential compliance
06/24/2010US20100160444 Method to inhibit ischemia and reperfusion injury
06/24/2010US20100160437 Topical composition comprising a cyclofructan, a carrier and a drug
06/24/2010US20100160405 Methods of using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline 1,3-dione
06/24/2010US20100160284 Carbapenem antibacterials with gram-negative activity and processes for their preparation
06/24/2010US20100160282 Novel diphenylazetidinones, process for their preparation, medicaments comprising these compounds and their use
06/24/2010US20100159607 Il1rl-1 as a cardiovascular disease marker and therapeutic target
06/24/2010US20100159439 Method for combined sequential agent delivery and electroporation for cell structures and use thereof
06/24/2010US20100159026 Colonic purgative composition with soluble binding agent
06/24/2010US20100158995 Systems for delivery and release of angiotensin-(1-7)
06/24/2010US20100158942 Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals
1 ... 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 ... 1151